News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Siegfried Shareholders Meeting Approves All Board Proposals


3/26/2014 2:05:19 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

26 March 2014 -- The Shareholders Meeting of Siegfried Holding AG to day approved all proposals by the Board of Directors. It endorsed a distribution to the Shareholders of CHF 1.50 per share, representing a 25% increase over that of the previous year, and elected Andreas Casutt as new Chairman and Wolfram Carius a s new member of the Board. Furthermore, it authorized a revision of Siegfried’ s articles of incorporation to meet new requirements.

Siegfried’s 111 th Annual Shareholders Meeting took place on 26 March 2014 in the Zofingen City Hall and was attended by around 250 shareholde rs and proxies representing about 54% of the shares. The Shareholders approved the follow ing:

The annual report, the financial statements and th e consolidated financial statements for 2013; discharge of the members of the Board of Directors; and the company’s compensation report on a consultative basis

Apropriation of retained earnings to free reserve s and distribution to shareholders from capital contribution reserves of CHF 1.50 per entitled registered share

General revision of Siegfried Holding AG’s article s of incorporation with adjustments to implement the new ordinance against excessive re muneration with regard to listed stock companies (the “Minder” Ordinance) which came into effect on 1 January 2014, and the creation of new limited capital of no more than CHF 420,000 permitting the creation of 210,000 fully liberated registered shares at CHF 2.00 par value as security for that part of remuneration whi ch is based on shares

Proposals concerning maximum remuneration of Board members until the 2015 Shareholders Meeting, fixed remuneration of Executi ve Management for the 2015 financial year and the long-term performance-relate d remuneration of Executive Management in the form of entitlements

All existing members of the Board were elected for a further term: Colin Bond, Andreas Casutt, Reto Garzetti, Felix K. Meyer and T homas Villiger, while Wolfram Carius was newly elected to the Board

Election of Andreas Casutt, former Vice-Chairman a nd a Board member since 2010, as Siegfried Holding AG’s new Chairman to succeed G ilbert Achermann, who previously announced his retirement

Separate election of the Remuneration Committee co nsisting of Reto Garzetti, Felix K. Meyer and Thomas Villiger

Appointment of BDO AG, Aarau, as independent proxy representative and PricewaterhouseCoopers AG, Basel, as auditors.

For further information:

Peter Gehler, Head Corporate Center

peter.gehler@siegfried.ch
Phone +41 (0)62 746 11 48
Mobile +41 (0)79 416 41 16
Fax +41 (0)62 746 11 03

Siegfried Holding AG
Untere Brühlstrasse 4
CH-4800 Zofingen
Tel. +41 (0)62 746 11 11
Fax +41 (0)62 746 11 03
www.siegfried.ch

About Siegfried

The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, Malta and the USA. At the end of 2013, Sieg fried reported annual sales of CHF 375 million and employs at the time being approximately 920 employe es. Siegfried Holding AG is listed on the Swiss Exchang e (SIX: SFZN).

Siegfried is active in both the primary and secondar y production of drugs. The company develops and manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediate steps and controlled sub stances, and provides development and production se rvices for drugs in finished dosage forms including steril e filling.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Siegfried
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES